Discover 512 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 512
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Iowa City IA, Hinsdale IL, Sioux Falls SD,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Iowa City IA, Westwood KS, Wichita KS, Birmingham AL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07190300
Phase1, Phase2, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
for
Hemophilia A
Location: Iowa City IA, Aurora CO
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416526
Phase3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Iowa City IA, Chicago IL, Milwaukee WI, St Louis MO,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase3, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Iowa City IA, Waukee IA, Rochester MN, Niles IL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
for
Hormone-receptor-positive Breast Cancer,
Location: Iowa City IA, Houston TX, Seattle WA
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06756932
Phase1, Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
for
Immunoglobulin A Nephropathy (IgAN)
Location: Iowa City IA, Edina MN, Acworth GA, Denver CO
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07146906
Phase2, Recruiting
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
for
Radiation-Induced Xerostomia and Hyposalivation
Location: Iowa City IA, Baltimore MD, Philadelphia PA,
Sponsor: RiboX Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06714253
Phase1, Phase2, Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Iowa City IA, Madison WI, Naperville IL,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase3, Recruiting
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
for
Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma
Location: Iowa City IA, Milwaukee WI, St Louis MO,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04040205
Phase2, Recruiting
Hyperbaric Oxygen Brain Injury Treatment Trial
for
Traumatic Brain Injury
Location: Iowa City IA, Minneapolis MN, Detroit MI, Lexington KY,
Sponsor: Gaylan Rockswold
Sex: All
Age: 16 - 65
Code: NCT02407028
Phase2, Recruiting
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
for
Epilepsy, SUDEP
Location: Iowa City IA
Sponsor: University of Iowa
Sex: All
Age: 18 - 70+
Code: NCT04134754
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Iowa City IA, Des Moines IA, Rochester MN,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Behavioral Economic & Staffing Strategies in the ICU